BioVie Inc., a Nevada corporation, announced the filing of a definitive proxy statement (DEF 14A) with the U.S. Securities and Exchange Commission (SEC) for its upcoming annual meeting of stockholders scheduled for November 7, 2024. The virtual meeting format will prevent in-person attendance but allows stockholders to participate online. The agenda includes the election of six directors, the ratification of EisnerAmper LLP as the independent registered public accounting firm for the fiscal year 2025, an advisory vote on executive compensation, and the approval of an amendment to the 2019 Omnibus Equity Incentive Plan to increase the number of shares authorized for issuance. The board has fixed September 30, 2024, as the record date, meaning only stockholders of record on this date are entitled to vote. The proxy materials, including the 2024 Annual Report and proxy card, will be available online and are being mailed to stockholders around October 9, 2024.

BioVie Inc., a Nevada corporation, announced the filing of a definitive proxy statement (DEF 14A) with the U.S. Securities and Exchange Commission (SEC) for its upcoming annual meeting of stockholders scheduled for November 7, 2024. The virtual meeting format will prevent in-person attendance but allows stockholders to participate online. The agenda includes the election of six directors, the ratification of EisnerAmper LLP as the independent registered public accounting firm for the fiscal year 2025, an advisory vote on executive compensation, and the approval of an amendment to the 2019 Omnibus Equity Incentive Plan to increase the number of shares authorized for issuance. The board has fixed September 30, 2024, as the record date, meaning only stockholders of record on this date are entitled to vote. The proxy materials, including the 2024 Annual Report and proxy card, will be available online and are being mailed to stockholders around October 9, 2024.